| Free Meta's Smart Glasses: A Bull Case on 50M Units, Bear Case on Privacy Commercial validation meets regulatory overhang—investors face a bifurcated outlook. By KAPUALabs / 19 Jun 2026
| Free The Alchemy of GLP-1: How Eli Lilly Formulated a Therapeutic Revolution From tirzepatide's surgical-level weight loss to oral orforglipron, a story of systematic advantage. By KAPUALabs / 19 Jun 2026
| Free Meta’s AI Capex: Bull Case vs. Bear Case on FCF and ROE Analyzing the bull case of advertising monetization against the bear case of near-zero free cash flow and rising depreciation. By KAPUALabs / 19 Jun 2026
| Free Meta Platforms: Balancing Hardware Innovation with Regulatory and Advertising Pressures A comprehensive analysis of Meta's Ray-Ban smart glasses traction, AI risks, advertising threats, and data privacy concerns. By KAPUALabs / 19 Jun 2026
| Free AI Regulation: Meta's Compliance Maze Navigating fragmented global rules from the EU AI Act to state-level mandates and Vatican ethics By KAPUALabs / 19 Jun 2026
| Free Meta's Bear Case Strengthens: Cybersecurity Risks Threaten Shareholder Value With PII breaches eroding trust and regulatory fines looming, Meta's security flaws become a material headwind. By KAPUALabs / 19 Jun 2026
| Free Big Tech Under Siege: Regulation and Security Reshape Meta's Messaging Strategy From EU AI mandates to spyware litigation, Meta balances openness with profitability. By KAPUALabs / 19 Jun 2026
| Free Meta in AI Era: Bull Case on Trust, Bear Case on Returns Institutional optimism scores Meta 73/100, but 95% of AI pilots yield no returns—investors face a trust vs. reality divide. By KAPUALabs / 19 Jun 2026
| Free Semaglutide vs Tirzepatide: A Formulation-Based Clinical Assessment Comprehensive analysis of efficacy, safety, and commercial implications for obesity treatment market. By KAPUALabs / 19 Jun 2026
| Free Meta's Optical Relay Strategy: UALink and Smart Glasses A detailed analysis of how Meta is decoupling from proprietary networks and securing optical supply chains. By KAPUALabs / 19 Jun 2026
| Free The AI Capex Conundrum: How Meta and Peers Are Redefining Free Cash Flow in 2026 Across technology, consumer, and industrial sectors, aggressive infrastructure investments reshape liquidity profiles. By KAPUALabs / 19 Jun 2026
| Free Meta's Advertising Machine: Scale, Risks, and the Subscription Pivot A comprehensive analysis of Meta's $196B ad business, its vulnerabilities, and its strategic shift toward recurring revenue models. By KAPUALabs / 19 Jun 2026
